OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Recommendation of “Moderate Buy” by Brokerages

OrthoPediatrics Corp. (NASDAQ:KIDS) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $24.6667.

A number of research analysts have recently issued reports on KIDS shares. Needham & Company LLC boosted their price target on shares of OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Truist Financial lifted their target price on shares of OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a research note on Monday. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a research report on Wednesday, December 10th. They set a “buy” rating and a $24.00 price target on the stock. Finally, Wall Street Zen lowered OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Saturday, February 21st.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently modified their holdings of KIDS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after buying an additional 645 shares during the period. Russell Investments Group Ltd. lifted its position in shares of OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after acquiring an additional 1,139 shares during the period. BNP Paribas Financial Markets boosted its stake in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in OrthoPediatrics by 12.4% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 15,901 shares of the company’s stock worth $342,000 after purchasing an additional 1,753 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after purchasing an additional 2,561 shares during the period. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Trading Down 2.9%

NASDAQ KIDS opened at $18.67 on Wednesday. The firm has a market capitalization of $468.24 million, a PE ratio of -11.05 and a beta of 1.07. The business’s 50-day moving average price is $17.70 and its two-hundred day moving average price is $18.12. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. OrthoPediatrics has a 12 month low of $15.28 and a 12 month high of $26.40.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.11. OrthoPediatrics had a negative return on equity of 6.68% and a negative net margin of 16.77%.The company had revenue of $61.61 million for the quarter, compared to analyst estimates of $61.27 million. On average, analysts expect that OrthoPediatrics will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.